AI
| Followers | 5 |
| Posts | 3 |
| Boards Moderated | 0 |
| Alias Born | 02/15/2018 |
Tuesday, April 19, 2022 7:08:07 PM
NWBO has no rights to ATL-DC.
What you're reading below is an email exchange between me and Denise Heady, a media relations contact at UCLA Jonsson Cancer Center. As you can see, this email exchange took place in the early weeks of 2020, right before Covid shut everything down.
Feel free to confirm on your own. Denise is no longer at UCLA but someone else there can certainly confirm this information. NWBO has no rights to ATL-DC, nor is it involved in the pembrolizumab combination study.
I hope this helps. -- Adam Feuerstein
What you're reading below is an email exchange between me and Denise Heady, a media relations contact at UCLA Jonsson Cancer Center. As you can see, this email exchange took place in the early weeks of 2020, right before Covid shut everything down.
Feel free to confirm on your own. Denise is no longer at UCLA but someone else there can certainly confirm this information. NWBO has no rights to ATL-DC, nor is it involved in the pembrolizumab combination study.
I hope this helps. -- Adam Feuerstein
